Gattai, Minoli, Agostinelli & Partners in the acquisition by CVC of the majority of Genetic Pharmaceutical Group

CVC Strategic Opportunities II signed the agreement for the acquisition of the majority of Genetic Pharmaceutical Group, a leading pharmaceutical company, specialized in the development and production of products for respiratory, ophthalmic and oncological treatments.

CVC will invest through a partnership with the family of the founder of Genetic, Rocco Pavese, who will act as CEO of the company and will continue to lead the research and development activities. Based in Fisciano, Campania, Genetic is s an integrated pharmaceutical company specialized in the research, development, production, registration and promotion of drugs and specific medical devices.

Gattai, Minoli, Agostinelli & Partners assisted CVC for the M&A aspects with a team led by Partner Gerardo Gabrielli, with counsel Lorenzo Fabbrini, senior associate Diletta Camicia and associates Silvia PinciroliMatteo Bortolotti and Tomaso Maria Morino as well as Micaela Tinti for the Pharma aspects.